Skip to content

Disc Medicine IRON Operating Cash Flow

Operating Cash Flow at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$1.1B-43.5%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.43B+74.4%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-$48.94M-139%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
-$118.92M-6.7%
Beam Therapeutics logo
Beam TherapeuticsBEAM
-$128.51M-23.7%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
-$40.37M+4.3%

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.69B+42.2%
Enterprise value$2.63B+46.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Disc Medicine's operating cash flow?
Disc Medicine (IRON) reported operating cash flow of -$62.24M in Q1 2026.
How has Disc Medicine's operating cash flow changed year-over-year?
Disc Medicine's operating cash flow decreased by 50.4% year-over-year, from -$41.38M to -$62.24M.
What is the long-term trend for Disc Medicine's operating cash flow?
Over 3 years (2022 to 2025), Disc Medicine's operating cash flow has grown at a 62.2% compound annual growth rate (CAGR), from -$42.25M to -$180.39M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.